Overview
Sebastien Malinge practices in Crawley, Australia. Mr. Malinge is rated as an Experienced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Acute Megakaryoblastic Leukemia, Down Syndrome, Leukemia, and L1 Syndrome.
His clinical research consists of co-authoring 37 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Megakaryoblastic Leukemia
- Distinguished
- Down SyndromeMr. Malinge isDistinguished. Learn about Down Syndrome.
- Advanced
- Acute Erythroid Leukemia (AEL)Mr. Malinge isAdvanced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Lymphoblastic Leukemia (ALL)Mr. Malinge isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Malinge isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- L1 SyndromeMr. Malinge isAdvanced. Learn about L1 Syndrome.
- LeukemiaMr. Malinge isAdvanced. Learn about Leukemia.
- VLDLR-Associated Cerebellar Hypoplasia
- Experienced
- Acute Cerebellar AtaxiaMr. Malinge isExperienced. Learn about Acute Cerebellar Ataxia.
- Myeloproliferative Neoplasms (MPN)Mr. Malinge isExperienced. Learn about Myeloproliferative Neoplasms (MPN).